Antiviral Oral Liquid Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Oral Liquid Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Syrup
1.2.3 Oral suspension
1.2.4 Oral solution
1.2.5 Oral drop
1.2.6 Oral emulsion
1.2.7 Mixture
1.3 Market by Application
1.3.1 Global Antiviral Oral Liquid Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antiviral Oral Liquid Market Perspective (2017-2028)
2.2 Antiviral Oral Liquid Growth Trends by Region
2.2.1 Antiviral Oral Liquid Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antiviral Oral Liquid Historic Market Size by Region (2017-2022)
2.2.3 Antiviral Oral Liquid Forecasted Market Size by Region (2023-2028)
2.3 Antiviral Oral Liquid Market Dynamics
2.3.1 Antiviral Oral Liquid Industry Trends
2.3.2 Antiviral Oral Liquid Market Drivers
2.3.3 Antiviral Oral Liquid Market Challenges
2.3.4 Antiviral Oral Liquid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiviral Oral Liquid Players by Revenue
3.1.1 Global Top Antiviral Oral Liquid Players by Revenue (2017-2022)
3.1.2 Global Antiviral Oral Liquid Revenue Market Share by Players (2017-2022)
3.2 Global Antiviral Oral Liquid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiviral Oral Liquid Revenue
3.4 Global Antiviral Oral Liquid Market Concentration Ratio
3.4.1 Global Antiviral Oral Liquid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Oral Liquid Revenue in 2021
3.5 Antiviral Oral Liquid Key Players Head office and Area Served
3.6 Key Players Antiviral Oral Liquid Product Solution and Service
3.7 Date of Enter into Antiviral Oral Liquid Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiviral Oral Liquid Breakdown Data by Type
4.1 Global Antiviral Oral Liquid Historic Market Size by Type (2017-2022)
4.2 Global Antiviral Oral Liquid Forecasted Market Size by Type (2023-2028)
5 Antiviral Oral Liquid Breakdown Data by Application
5.1 Global Antiviral Oral Liquid Historic Market Size by Application (2017-2022)
5.2 Global Antiviral Oral Liquid Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antiviral Oral Liquid Market Size (2017-2028)
6.2 North America Antiviral Oral Liquid Market Size by Type
6.2.1 North America Antiviral Oral Liquid Market Size by Type (2017-2022)
6.2.2 North America Antiviral Oral Liquid Market Size by Type (2023-2028)
6.2.3 North America Antiviral Oral Liquid Market Share by Type (2017-2028)
6.3 North America Antiviral Oral Liquid Market Size by Application
6.3.1 North America Antiviral Oral Liquid Market Size by Application (2017-2022)
6.3.2 North America Antiviral Oral Liquid Market Size by Application (2023-2028)
6.3.3 North America Antiviral Oral Liquid Market Share by Application (2017-2028)
6.4 North America Antiviral Oral Liquid Market Size by Country
6.4.1 North America Antiviral Oral Liquid Market Size by Country (2017-2022)
6.4.2 North America Antiviral Oral Liquid Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antiviral Oral Liquid Market Size (2017-2028)
7.2 Europe Antiviral Oral Liquid Market Size by Type
7.2.1 Europe Antiviral Oral Liquid Market Size by Type (2017-2022)
7.2.2 Europe Antiviral Oral Liquid Market Size by Type (2023-2028)
7.2.3 Europe Antiviral Oral Liquid Market Share by Type (2017-2028)
7.3 Europe Antiviral Oral Liquid Market Size by Application
7.3.1 Europe Antiviral Oral Liquid Market Size by Application (2017-2022)
7.3.2 Europe Antiviral Oral Liquid Market Size by Application (2023-2028)
7.3.3 Europe Antiviral Oral Liquid Market Share by Application (2017-2028)
7.4 Europe Antiviral Oral Liquid Market Size by Country
7.4.1 Europe Antiviral Oral Liquid Market Size by Country (2017-2022)
7.4.2 Europe Antiviral Oral Liquid Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiviral Oral Liquid Market Size (2017-2028)
8.2 Asia-Pacific Antiviral Oral Liquid Market Size by Type
8.2.1 Asia-Pacific Antiviral Oral Liquid Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antiviral Oral Liquid Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antiviral Oral Liquid Market Share by Type (2017-2028)
8.3 Asia-Pacific Antiviral Oral Liquid Market Size by Application
8.3.1 Asia-Pacific Antiviral Oral Liquid Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antiviral Oral Liquid Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antiviral Oral Liquid Market Share by Application (2017-2028)
8.4 Asia-Pacific Antiviral Oral Liquid Market Size by Region
8.4.1 Asia-Pacific Antiviral Oral Liquid Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antiviral Oral Liquid Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antiviral Oral Liquid Market Size (2017-2028)
9.2 Latin America Antiviral Oral Liquid Market Size by Type
9.2.1 Latin America Antiviral Oral Liquid Market Size by Type (2017-2022)
9.2.2 Latin America Antiviral Oral Liquid Market Size by Type (2023-2028)
9.2.3 Latin America Antiviral Oral Liquid Market Share by Type (2017-2028)
9.3 Latin America Antiviral Oral Liquid Market Size by Application
9.3.1 Latin America Antiviral Oral Liquid Market Size by Application (2017-2022)
9.3.2 Latin America Antiviral Oral Liquid Market Size by Application (2023-2028)
9.3.3 Latin America Antiviral Oral Liquid Market Share by Application (2017-2028)
9.4 Latin America Antiviral Oral Liquid Market Size by Country
9.4.1 Latin America Antiviral Oral Liquid Market Size by Country (2017-2022)
9.4.2 Latin America Antiviral Oral Liquid Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiviral Oral Liquid Market Size (2017-2028)
10.2 Middle East & Africa Antiviral Oral Liquid Market Size by Type
10.2.1 Middle East & Africa Antiviral Oral Liquid Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antiviral Oral Liquid Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antiviral Oral Liquid Market Share by Type (2017-2028)
10.3 Middle East & Africa Antiviral Oral Liquid Market Size by Application
10.3.1 Middle East & Africa Antiviral Oral Liquid Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antiviral Oral Liquid Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antiviral Oral Liquid Market Share by Application (2017-2028)
10.4 Middle East & Africa Antiviral Oral Liquid Market Size by Country
10.4.1 Middle East & Africa Antiviral Oral Liquid Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antiviral Oral Liquid Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Antiviral Oral Liquid Introduction
11.1.4 Pfizer Revenue in Antiviral Oral Liquid Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Antiviral Oral Liquid Introduction
11.2.4 Roche Revenue in Antiviral Oral Liquid Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Antiviral Oral Liquid Introduction
11.3.4 Novartis Revenue in Antiviral Oral Liquid Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Antiviral Oral Liquid Introduction
11.4.4 Merck Revenue in Antiviral Oral Liquid Business (2017-2022)
11.4.5 Merck Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Antiviral Oral Liquid Introduction
11.5.4 GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Antiviral Oral Liquid Introduction
11.6.4 Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2017-2022)
11.6.5 Johnson & Johnson Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Antiviral Oral Liquid Introduction
11.7.4 AbbVie Revenue in Antiviral Oral Liquid Business (2017-2022)
11.7.5 AbbVie Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Antiviral Oral Liquid Introduction
11.8.4 Sanofi Revenue in Antiviral Oral Liquid Business (2017-2022)
11.8.5 Sanofi Recent Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Antiviral Oral Liquid Introduction
11.9.4 Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2017-2022)
11.9.5 Bristol-Myers Squibb Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Antiviral Oral Liquid Introduction
11.10.4 AstraZeneca Revenue in Antiviral Oral Liquid Business (2017-2022)
11.10.5 AstraZeneca Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Antiviral Oral Liquid Introduction
11.11.4 Eli Lilly Revenue in Antiviral Oral Liquid Business (2017-2022)
11.11.5 Eli Lilly Recent Developments
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Details
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Antiviral Oral Liquid Introduction
11.12.4 Novo Nordisk Revenue in Antiviral Oral Liquid Business (2017-2022)
11.12.5 Novo Nordisk Recent Developments
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Antiviral Oral Liquid Introduction
11.13.4 Amgen Revenue in Antiviral Oral Liquid Business (2017-2022)
11.13.5 Amgen Recent Developments
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Antiviral Oral Liquid Introduction
11.14.4 Gilead Sciences Revenue in Antiviral Oral Liquid Business (2017-2022)
11.14.5 Gilead Sciences Recent Developments
11.15 CSL
11.15.1 CSL Company Details
11.15.2 CSL Business Overview
11.15.3 CSL Antiviral Oral Liquid Introduction
11.15.4 CSL Revenue in Antiviral Oral Liquid Business (2017-2022)
11.15.5 CSL Recent Developments
11.16 Takeda Pharmaceuticals
11.16.1 Takeda Pharmaceuticals Company Details
11.16.2 Takeda Pharmaceuticals Business Overview
11.16.3 Takeda Pharmaceuticals Antiviral Oral Liquid Introduction
11.16.4 Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2017-2022)
11.16.5 Takeda Pharmaceuticals Recent Developments
11.17 Bayer
11.17.1 Bayer Company Details
11.17.2 Bayer Business Overview
11.17.3 Bayer Antiviral Oral Liquid Introduction
11.17.4 Bayer Revenue in Antiviral Oral Liquid Business (2017-2022)
11.17.5 Bayer Recent Developments
11.18 Celgene
11.18.1 Celgene Company Details
11.18.2 Celgene Business Overview
11.18.3 Celgene Antiviral Oral Liquid Introduction
11.18.4 Celgene Revenue in Antiviral Oral Liquid Business (2017-2022)
11.18.5 Celgene Recent Developments
11.19 Merck KGaA
11.19.1 Merck KGaA Company Details
11.19.2 Merck KGaA Business Overview
11.19.3 Merck KGaA Antiviral Oral Liquid Introduction
11.19.4 Merck KGaA Revenue in Antiviral Oral Liquid Business (2017-2022)
11.19.5 Merck KGaA Recent Developments
11.20 Allergan
11.20.1 Allergan Company Details
11.20.2 Allergan Business Overview
11.20.3 Allergan Antiviral Oral Liquid Introduction
11.20.4 Allergan Revenue in Antiviral Oral Liquid Business (2017-2022)
11.20.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antiviral Oral Liquid Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Syrup
Table 3. Key Players of Oral suspension
Table 4. Key Players of Oral solution
Table 5. Key Players of Oral drop
Table 6. Key Players of Oral emulsion
Table 7. Key Players of Mixture
Table 8. Global Antiviral Oral Liquid Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Antiviral Oral Liquid Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Antiviral Oral Liquid Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Antiviral Oral Liquid Market Share by Region (2017-2022)
Table 12. Global Antiviral Oral Liquid Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Antiviral Oral Liquid Market Share by Region (2023-2028)
Table 14. Antiviral Oral Liquid Market Trends
Table 15. Antiviral Oral Liquid Market Drivers
Table 16. Antiviral Oral Liquid Market Challenges
Table 17. Antiviral Oral Liquid Market Restraints
Table 18. Global Antiviral Oral Liquid Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Antiviral Oral Liquid Revenue Share by Players (2017-2022)
Table 20. Global Top Antiviral Oral Liquid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Oral Liquid as of 2021)
Table 21. Ranking of Global Top Antiviral Oral Liquid Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Antiviral Oral Liquid Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antiviral Oral Liquid Product Solution and Service
Table 25. Date of Enter into Antiviral Oral Liquid Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antiviral Oral Liquid Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Antiviral Oral Liquid Revenue Market Share by Type (2017-2022)
Table 29. Global Antiviral Oral Liquid Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Antiviral Oral Liquid Revenue Market Share by Type (2023-2028)
Table 31. Global Antiviral Oral Liquid Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Antiviral Oral Liquid Revenue Share by Application (2017-2022)
Table 33. Global Antiviral Oral Liquid Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Antiviral Oral Liquid Revenue Share by Application (2023-2028)
Table 35. North America Antiviral Oral Liquid Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Antiviral Oral Liquid Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Antiviral Oral Liquid Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Antiviral Oral Liquid Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Antiviral Oral Liquid Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Antiviral Oral Liquid Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Antiviral Oral Liquid Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Antiviral Oral Liquid Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Antiviral Oral Liquid Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Antiviral Oral Liquid Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Antiviral Oral Liquid Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Antiviral Oral Liquid Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Antiviral Oral Liquid Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Antiviral Oral Liquid Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Antiviral Oral Liquid Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Antiviral Oral Liquid Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Antiviral Oral Liquid Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Antiviral Oral Liquid Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Antiviral Oral Liquid Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Antiviral Oral Liquid Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Antiviral Oral Liquid Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Antiviral Oral Liquid Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Antiviral Oral Liquid Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Antiviral Oral Liquid Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Antiviral Oral Liquid Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Antiviral Oral Liquid Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Antiviral Oral Liquid Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Antiviral Oral Liquid Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Antiviral Oral Liquid Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Antiviral Oral Liquid Market Size by Country (2023-2028) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Antiviral Oral Liquid Product
Table 68. Pfizer Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 69. Pfizer Recent Developments
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Antiviral Oral Liquid Product
Table 73. Roche Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 74. Roche Recent Developments
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Antiviral Oral Liquid Product
Table 78. Novartis Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 79. Novartis Recent Developments
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Antiviral Oral Liquid Product
Table 83. Merck Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 84. Merck Recent Developments
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Antiviral Oral Liquid Product
Table 88. GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 89. GlaxoSmithKline Recent Developments
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Antiviral Oral Liquid Product
Table 93. Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 94. Johnson & Johnson Recent Developments
Table 95. AbbVie Company Details
Table 96. AbbVie Business Overview
Table 97. AbbVie Antiviral Oral Liquid Product
Table 98. AbbVie Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 99. AbbVie Recent Developments
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Antiviral Oral Liquid Product
Table 103. Sanofi Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 104. Sanofi Recent Developments
Table 105. Bristol-Myers Squibb Company Details
Table 106. Bristol-Myers Squibb Business Overview
Table 107. Bristol-Myers Squibb Antiviral Oral Liquid Product
Table 108. Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 109. Bristol-Myers Squibb Recent Developments
Table 110. AstraZeneca Company Details
Table 111. AstraZeneca Business Overview
Table 112. AstraZeneca Antiviral Oral Liquid Product
Table 113. AstraZeneca Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 114. AstraZeneca Recent Developments
Table 115. Eli Lilly Company Details
Table 116. Eli Lilly Business Overview
Table 117. Eli Lilly Antiviral Oral Liquid Product
Table 118. Eli Lilly Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 119. Eli Lilly Recent Developments
Table 120. Novo Nordisk Company Details
Table 121. Novo Nordisk Business Overview
Table 122. Novo Nordisk Antiviral Oral Liquid Product
Table 123. Novo Nordisk Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 124. Novo Nordisk Recent Developments
Table 125. Amgen Company Details
Table 126. Amgen Business Overview
Table 127. Amgen Antiviral Oral Liquid Product
Table 128. Amgen Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 129. Amgen Recent Developments
Table 130. Gilead Sciences Company Details
Table 131. Gilead Sciences Business Overview
Table 132. Gilead Sciences Antiviral Oral Liquid Product
Table 133. Gilead Sciences Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 134. Gilead Sciences Recent Developments
Table 135. CSL Company Details
Table 136. CSL Business Overview
Table 137. CSL Antiviral Oral Liquid Product
Table 138. CSL Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 139. CSL Recent Developments
Table 140. Takeda Pharmaceuticals Company Details
Table 141. Takeda Pharmaceuticals Business Overview
Table 142. Takeda Pharmaceuticals Antiviral Oral Liquid Product
Table 143. Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 144. Takeda Pharmaceuticals Recent Developments
Table 145. Bayer Company Details
Table 146. Bayer Business Overview
Table 147. Bayer Antiviral Oral Liquid Product
Table 148. Bayer Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 149. Bayer Recent Developments
Table 150. Celgene Company Details
Table 151. Celgene Business Overview
Table 152. Celgene Antiviral Oral Liquid Product
Table 153. Celgene Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 154. Celgene Recent Developments
Table 155. Merck KGaA Company Details
Table 156. Merck KGaA Business Overview
Table 157. Merck KGaA Antiviral Oral Liquid Product
Table 158. Merck KGaA Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 159. Merck KGaA Recent Developments
Table 160. Allergan Company Details
Table 161. Allergan Business Overview
Table 162. Allergan Antiviral Oral Liquid Product
Table 163. Allergan Revenue in Antiviral Oral Liquid Business (2017-2022) & (US$ Million)
Table 164. Allergan Recent Developments
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiviral Oral Liquid Market Share by Type: 2021 VS 2028
Figure 2. Syrup Features
Figure 3. Oral suspension Features
Figure 4. Oral solution Features
Figure 5. Oral drop Features
Figure 6. Oral emulsion Features
Figure 7. Mixture Features
Figure 8. Global Antiviral Oral Liquid Market Share by Application: 2021 VS 2028
Figure 9. Adults Case Studies
Figure 10. Children Case Studies
Figure 11. Antiviral Oral Liquid Report Years Considered
Figure 12. Global Antiviral Oral Liquid Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Antiviral Oral Liquid Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Antiviral Oral Liquid Market Share by Region: 2021 VS 2028
Figure 15. Global Antiviral Oral Liquid Market Share by Players in 2021
Figure 16. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Oral Liquid as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Antiviral Oral Liquid Revenue in 2021
Figure 18. North America Antiviral Oral Liquid Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Antiviral Oral Liquid Market Size Market Share by Type (2017-2028)
Figure 20. North America Antiviral Oral Liquid Market Size Market Share by Application (2017-2028)
Figure 21. North America Antiviral Oral Liquid Market Size Share by Country (2017-2028)
Figure 22. United States Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Antiviral Oral Liquid Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Antiviral Oral Liquid Market Size Market Share by Type (2017-2028)
Figure 26. Europe Antiviral Oral Liquid Market Size Market Share by Application (2017-2028)
Figure 27. Europe Antiviral Oral Liquid Market Size Share by Country (2017-2028)
Figure 28. Germany Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Antiviral Oral Liquid Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Antiviral Oral Liquid Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Antiviral Oral Liquid Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Antiviral Oral Liquid Market Size Share by Region (2017-2028)
Figure 38. China Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Antiviral Oral Liquid Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Antiviral Oral Liquid Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Antiviral Oral Liquid Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Antiviral Oral Liquid Market Size Share by Country (2017-2028)
Figure 48. Mexico Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Antiviral Oral Liquid Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Antiviral Oral Liquid Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Antiviral Oral Liquid Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Antiviral Oral Liquid Market Size Share by Country (2017-2028)
Figure 54. Turkey Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Antiviral Oral Liquid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 58. Roche Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 60. Merck Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 62. Johnson & Johnson Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 63. AbbVie Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 64. Sanofi Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 66. AstraZeneca Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 67. Eli Lilly Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 68. Novo Nordisk Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 69. Amgen Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 70. Gilead Sciences Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 71. CSL Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 72. Takeda Pharmaceuticals Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 73. Bayer Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 74. Celgene Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 75. Merck KGaA Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 76. Allergan Revenue Growth Rate in Antiviral Oral Liquid Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Industry Market Size
